Warning! GuruFocus has detected 5 Severe warning signs with IDXG. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Also Trade In: Germany
Current and historical daily P/E ratio for Interpace Biosciences Inc () from 1998 to Jun 19 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Interpace Biosciences stock (IDXG) PE ratio as of Jun 19 2021 is 0. More Details
Interpace Biosciences PE Ratio (TTM) Historical Data
View and export this data going back to 1998. Start your Free Trial
Interpace Biosciences PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
300 Interpace Parkway, Morris Corporate Center 1, Building C, Parsippany, NJ, USA, 07054
Interpace Biosciences Inc is engaged in the life sciences industry. It provides complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. It operates under one segment which is the business of developing and selling diagnostic clinical and pharma services.